{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T21:11:50Z","timestamp":1791234710723,"version":"4.1.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["journal-of-hepatology.eu","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.jhep.2017.10.018","type":"journal-article","created":{"date-parts":[[2017,10,26]],"date-time":"2017-10-26T21:32:55Z","timestamp":1509053575000},"page":"476-484","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":118,"title":["Statin use and the risk of hepatocellular carcinoma in patients at high risk: A nationwide nested case-control study"],"prefix":"10.1016","volume":"68","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6629-5727","authenticated-orcid":false,"given":"Gyuri","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suk-Yong","family":"Jang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chung Mo","family":"Nam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun Seok","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhep.2017.10.018_b0005","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1016\/S0140-6736(10)61350-5","article-title":"Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials","volume":"376","author":"Baigent","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.jhep.2017.10.018_b0010","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1038\/nrc1751","article-title":"Statins and cancer prevention","volume":"5","author":"Demierre","year":"2005","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.jhep.2017.10.018_b0015","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.3349\/ymj.2016.57.5.1124","article-title":"Concomitant statin use has a favorable effect on gemcitabine-erlotinib combination chemotherapy for advanced pancreatic cancer","volume":"57","author":"Moon do","year":"2016","journal-title":"Yonsei Med J"},{"key":"10.1016\/j.jhep.2017.10.018_b0020","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1038\/nrc.2016.76","article-title":"The interplay between cell signalling and the mevalonate pathway in cancer","volume":"16","author":"Mullen","year":"2016","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.jhep.2017.10.018_b0025","doi-asserted-by":"crossref","first-page":"71","DOI":"10.4137\/CMO.S9926","article-title":"Emerging trends in hepatocellular carcinoma: focus on diagnosis and therapeutics","volume":"8","author":"Flores","year":"2014","journal-title":"Clin Med Insights Oncol"},{"key":"10.1016\/j.jhep.2017.10.018_b0030","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.bpg.2014.08.007","article-title":"Hepatocellular carcinoma epidemiology","volume":"28","author":"Bosetti","year":"2014","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"10.1016\/j.jhep.2017.10.018_b0035","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1053\/j.gastro.2004.09.011","article-title":"Primary liver cancer: worldwide incidence and trends","volume":"127","author":"Bosch","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2017.10.018_b0040","doi-asserted-by":"crossref","first-page":"817","DOI":"10.7326\/0003-4819-139-10-200311180-00009","article-title":"The continuing increase in the incidence of hepatocellular carcinoma in the United States: an update","volume":"139","author":"El-Serag","year":"2003","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jhep.2017.10.018_b0045","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1055\/s-0030-1247128","article-title":"Hepatocellular carcinoma: epidemiology, surveillance, and diagnosis","volume":"30","author":"Sherman","year":"2010","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.jhep.2017.10.018_b0050","doi-asserted-by":"crossref","first-page":"4161","DOI":"10.1200\/JCO.2013.51.5593","article-title":"Common flaws in pharmacoepidemiologic study design and analysis","volume":"31","author":"Lund","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jhep.2017.10.018_b0055","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1053\/j.gastro.2003.10.065","article-title":"Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma","volume":"126","author":"El-Serag","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2017.10.018_b0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12328-014-0548-5","article-title":"Clinical features of hepatocellular carcinoma associated with nonalcoholic fatty liver disease: a review of human studies","volume":"8","author":"Oda","year":"2015","journal-title":"Clin J Gastroenterol"},{"key":"10.1016\/j.jhep.2017.10.018_b0065","doi-asserted-by":"crossref","first-page":"6","DOI":"10.3803\/EnM.2017.32.1.6","article-title":"The SCAP\/SREBP pathway: a mediator of hepatic steatosis","volume":"32","author":"Moon","year":"2017","journal-title":"Endocrinol Metab"},{"key":"10.1016\/j.jhep.2017.10.018_b0070","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0140-6736(08)60104-X","article-title":"Efficacy of cholesterol-lowering therapy in 18,686 people with diabetes in 14 randomised trials of statins: a meta-analysis","volume":"371","author":"Kearney","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.jhep.2017.10.018_b0075","doi-asserted-by":"crossref","first-page":"32","DOI":"10.4093\/dmj.2014.38.1.32","article-title":"Statin for the primary prevention of cardiovascular disease in patients with diabetes mellitus","volume":"38","author":"Koo","year":"2014","journal-title":"Diabetes Metab J"},{"key":"10.1016\/j.jhep.2017.10.018_b0080","first-page":"e15","article-title":"Cohort profile: the national health insurance service-national sample cohort (NHIS-NSC), South Korea","volume":"46","author":"Lee","year":"2017","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.jhep.2017.10.018_b0085","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1093\/jnci\/djs452","article-title":"Nonsteroidal anti-inflammatory drug use, chronic liver disease, and hepatocellular carcinoma","volume":"104","author":"Sahasrabuddhe","year":"2012","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.jhep.2017.10.018_b0090","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1097\/01.mlr.0000182534.19832.83","article-title":"Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data","volume":"43","author":"Quan","year":"2005","journal-title":"Med Care"},{"key":"10.1016\/j.jhep.2017.10.018_b0095","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.2337\/diabetes.50.8.1844","article-title":"Nonalcoholic fatty liver disease: a feature of the metabolic syndrome","volume":"50","author":"Marchesini","year":"2001","journal-title":"Diabetes"},{"key":"10.1016\/j.jhep.2017.10.018_b0100","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1111\/j.1572-0241.2003.07485.x","article-title":"Elevated AST or ALT to nonalcoholic fatty liver disease: accurate predictor of disease prevalence?","volume":"98","author":"Yu","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhep.2017.10.018_b0105","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1002\/hep.21327","article-title":"Long-term follow-up of patients with NAFLD and elevated liver enzymes","volume":"44","author":"Ekstedt","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2017.10.018_b0110","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s40557-016-0105-4","article-title":"Risks of borderline liver enzyme abnormalities to the incidence of impaired fasting glucose and diabetes mellitus: a 7 year follow up study of workers","volume":"28","author":"Yu","year":"2016","journal-title":"Ann Occup Environ Med"},{"key":"10.1016\/j.jhep.2017.10.018_b0115","doi-asserted-by":"crossref","first-page":"275","DOI":"10.2337\/diacare.25.2.275","article-title":"Defining the relationship between plasma glucose and HbA(1c): analysis of glucose profiles and HbA(1c) in the Diabetes Control and Complications Trial","volume":"25","author":"Rohlfing","year":"2002","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jhep.2017.10.018_b0120","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1002\/ijc.30506","article-title":"Effect of statin on hepatocellular carcinoma in patients with type 2 diabetes: A nationwide nested case-control study","volume":"140","author":"Kim","year":"2017","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jhep.2017.10.018_b0125","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1002\/cncr.24982","article-title":"Association of diabetes duration and diabetes treatment with the risk of hepatocellular carcinoma","volume":"116","author":"Hassan","year":"2010","journal-title":"Cancer"},{"key":"10.1016\/j.jhep.2017.10.018_b0130","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1200\/JCO.2012.44.6831","article-title":"Statins and the risk of hepatocellular carcinoma in patients with hepatitis C virus infection","volume":"31","author":"Tsan","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jhep.2017.10.018_b0135","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1200\/JCO.2011.36.0917","article-title":"Statins and the risk of hepatocellular carcinoma in patients with hepatitis B virus infection","volume":"30","author":"Tsan","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jhep.2017.10.018_b0140","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djv009","article-title":"Statin use and risk of primary liver cancer in the Clinical Practice Research Datalink","volume":"107","author":"McGlynn","year":"2015","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.jhep.2017.10.018_b0145","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1124\/dmd.30.11.1158","article-title":"Liver-specific distribution of rosuvastatin in rats: comparison with pravastatin and simvastatin","volume":"30","author":"Nezasa","year":"2002","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.jhep.2017.10.018_b0150","first-page":"1317","article-title":"Simvastatin and lovastatin inhibit breast cell invasion induced by H-Ras","volume":"21","author":"Kang","year":"2009","journal-title":"Oncol Rep"},{"key":"10.1016\/j.jhep.2017.10.018_b0155","doi-asserted-by":"crossref","first-page":"4772","DOI":"10.1158\/0008-5472.CAN-14-0130","article-title":"Immediate utility of two approved agents to target both the metabolic mevalonate pathway and its restorative feedback loop","volume":"74","author":"Pandyra","year":"2014","journal-title":"Cancer Res"},{"key":"10.1016\/j.jhep.2017.10.018_b0160","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.jhep.2007.02.013","article-title":"Statins in non-alcoholic fatty liver disease and chronically elevated liver enzymes: a histopathological follow-up study","volume":"47","author":"Ekstedt","year":"2007","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2017.10.018_b0165","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1038\/ajg.2016.179","article-title":"Statins reduce the risk of cirrhosis and its decompensation in chronic hepatitis B patients: a nationwide cohort study","volume":"111","author":"Huang","year":"2016","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhep.2017.10.018_b0170","doi-asserted-by":"crossref","first-page":"376","DOI":"10.4093\/dmj.2016.40.5.376","article-title":"Statins increase mitochondrial and peroxisomal fatty acid oxidation in the liver and prevent non-alcoholic steatohepatitis in mice","volume":"40","author":"Park","year":"2016","journal-title":"Diabetes Metab J"},{"key":"10.1016\/j.jhep.2017.10.018_b0175","series-title":"Basic study designs in analytic epidemiology epidemiology beyond the basics","first-page":"27","author":"Szklo","year":"2014"},{"key":"10.1016\/j.jhep.2017.10.018_b0180","series-title":"Errors in hypothesis testing. Medical Statistics at a Glance","first-page":"52","author":"Petrie","year":"2009"}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827817323978?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827817323978?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,26]],"date-time":"2018-08-26T09:25:56Z","timestamp":1535275556000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168827817323978"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":36,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["S0168827817323978"],"URL":"https:\/\/doi.org\/10.1016\/j.jhep.2017.10.018","relation":{},"ISSN":["0168-8278"],"issn-type":[{"value":"0168-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Statin use and the risk of hepatocellular carcinoma in patients at high risk: A nationwide nested case-control study","name":"articletitle","label":"Article Title"},{"value":"Journal of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhep.2017.10.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}